Progress in Regional Cancer Therapy pp 145-148 | Cite as
Intratumoral Treatment of Incurable Head and Neck Cancer with Recombinant Human Tumor Necrosis Factor-α
Conference paper
Abstract
As early as 1893 Coley [5] observed a patient whose sarcoma showed hemorrhagic necrotization in the course of an infection with erysipelas. Subsequent experiments revealed that bacterial polysaccharides might be the cause of this hemorrhagic tumor necrosis.
Keywords
Ischemic Necrosis Mixed Lymphocyte Culture Neck Metastasis Bacterial Polysaccharide Serum Neopterin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Bartsch HH, Golms R, Nagel G A (1988) Intralesional application of recombinant tumor-necrosis factor-alpha in patients with advanced malignancies. Workshop:Progress in Regional Cancer Therapy I, abstract 244, p 143Google Scholar
- 2.Beutler B, Greenwald D, Hulmes JD et al. (1985) Identity of tumor necrosis factor and the macrophage secreted factor cachectin. Nature 316:552–554PubMedCrossRefGoogle Scholar
- 3.Blick M, Sherwin SA, Rosenblum M, Gutterman J (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47:2986–2989PubMedGoogle Scholar
- 4.Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670PubMedCrossRefGoogle Scholar
- 5.Coley WB (1893) The treatment of malignant tumors by repeated inoculations of erysipelas; with a report of ten original cases. Am J Med Sci 105:487–511CrossRefGoogle Scholar
- 6.Pennica D, Nedwin GE, Hayflick JS et al. (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724–729PubMedCrossRefGoogle Scholar
- 7.Pfreundschuh M, Schaadt M, Steinmetz T, Tuschen R, Schenk V, Diehl V (1989) Phase-I-study of intratumoral application of recombinant human tumor necrosis factor. Int J Cancer (in press)Google Scholar
- 8.Ruff M, Gifford GE (1981) Tumor necrosis factor. In: Pick E (ed) Lymphokines vol 2. Academic, New York, pp 235–272Google Scholar
- 9.Taguchi T, Shiratori T, Kodama M, Takahashi T, Okajima K, Mori T et al. (1986) Clinical studies of recombinant human tumor necrosis factor (rHu-TNF:PT-050). Proceedings of the 14th International Cancer Congress, Budapest, abstract 4455, p 1159Google Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 1990